Shivang R. Dave, PhD, is CEO and Co-Founder of PlenOptika, which designs and produces tools to vastly expand access to vision care globally. As CEO, Shivang led PlenOptika’s growth from startup to an international company with products in global distribution, improving vision for millions of patients worldwide. A passionate advocate for technology innovation to address care disparities, Shivang has positioned PlenOptika as a thought leader in vision health research, optical care, and global health policy with strong strategic partnerships in academia, industry, and public health. He earned his undergraduate degree from UC Berkeley and doctorate in Bioengineering and Nanotechnology from the University of Washington, and completed an advanced research fellowship at the Massachusetts Institute of Technology. A veteran of two commercial startups prior to PlenOptika, Shivang mentors rising entrepreneurs by sharing his experiences and insights regarding innovation, translational medicine, and leadership.
Daryl Lim has been involved in both technical and business sides of the biomedical industry. He received a B.S. in Physics from the University of Leipzig and a Ph.D. in Biomedical Engineering from Boston University. Following that, he did a postdoctoral fellowship at MIT where he developed diagnostic technologies for ophthalmology and oncology. As a management consultant at McKinsey & Company, Daryl worked with some of the largest companies in the med-tech, healthcare, and pharma sectors in a variety of projects spanning operations, strategy, organization, and more.
Eduardo Lage, a native of Spain, received his undergraduate degree in Electronic Engineering from the University of Alcala (Madrid) and his PhD in Medical Imaging from the University Politecnica of Madrid. He began his career in Medical Imaging by joining the Medical Imaging Lab of the Gregorio Marañon Hospital to help in the development of a Positron Emission Tomography (PET) system for small-animal imaging. From that time, Eduardo Lage has focused his career on exploring innovative approaches for molecular imaging. Dr. Lage has led or participated in the design and development of various preclinical scanners (PET, SPECT, CT and multimodality systems) which have been commercialized by several companies such as SEDECAL S.A. (Madrid) and General Electric (USA).
Managing Partner, Future Communities Capital
Founder & Managing Partner, Nina Capital
Partner, Oakhouse Partners
Board Advisor
CEO, OptimizeRX Corporation
Vice President, Senior Quant – Fixed Income Beta Desk, State Street Global Advisors
Clinical Trainer, Georgia Eye Partners
Vice President, Professional Affairs at New England College of Optometry
Chief of Retina Division, Stanford University School of Medicine; Chief Medical Officer, WALDO
President at Dave Sattler Consulting Services; formerly, Director Professional Relations at Alcon
Associate Director, Medical Affairs at Regeneron
Associate Clinical Professor, Director of Clinical Externships, and Director of New Technologies at State University of New York College of Optometry
QuickSee Free
QuickSee Free Pro Keratometry
QuickSee Free Software
QuickSee
© 2024 PlenOptika. All rights reserved. | No. RII-AEE: 14923 | No. RII-PyA: 4987
Are you ready to learn how to use QuickSee Free / Free Pro effectively? Tell us about yourself and your circumstances and we will reach out to arrange a training session with you.
QuickSee Free Pro flew on the history-making Polaris Dawn mission to measure changes in the astronauts’ vision